【レポートの概要（一部）】
1. Report Overview
1.1 Overview of the Top Needle-Free Injection Device Manufacturers
1.2 Why You Should Read This Report
1.3 How This Report Delivers Research and Analysis
1.4 Main Questions Answered by This Analytical Study
1.5 Who is This Report For?
1.6 Methodology
1.7 Frequently Asked Questions (FAQ)
1.8 Associated Visiongain Reports
1.9 About Visiongain
2. Introduction to Needle-Free Injection
2.1 What is Needle-Free Drug Delivery?
2.1.1 History of Needle-Free Injections: From Military to Clinic
2.1.2 Modern Needle-Free Devices: Concept of High Pressure Fluid Jet
2.2 What is the Rationale for Needle-Free Injections?
2.3 Applications of Needle-Free Drug Delivery
2.3.1 Pain Management: Using NFI Devices to Administer Lidocaine
2.3.2 Vaccine Delivery: Improving Immune Response
2.3.3 Insulin Delivery: Jet Injection Enhances Drug Distribution
2.3.4 Paediatrics: Alleviating Childhood Anxiety and Phobia
2.4 Regulation of Needle-Free Delivery Devices
2.4.1 The US Regulation System: Prolonged Approval Process
2.4.2 The European Regulation System: Manufacturers Seeking EU Approval First?
2.5 Advantages and Disadvantages of Needle-Free Systems
3. The Global Needle-Free Injection Devices Market, 2016-2026
3.1 The Global Needle-Free Injection Device Market, 2016
3.2 The Global Needle-Free Injection Device Market: Revenue Forecast, 2016-2026
3.3 What Will Drive The Global Needle-Free Injection Device Market Between 2016 and 2026?
3.4 What Factors are Likely to Restrain the Global Needle-Free Injection Device Market Between 2016 and 2026?
3.5 The Global Jet Injector Device Market, 2016
3.5.1 The Global Jet Injector Device Market: Industry Trends, 2016-2026
3.6 The Global Competing Technologies Market, 2016
3.6.1 The Global Competing Technologies Market: Industry Trends, 2016-2026
3.6.1.1 Transdermal Patches: Attractive and Cheap Option
3.6.1.2 Microneedle Technology: Huge Potential for Mass Vaccinations
3.6.1.3 Metered Dose Inhalers: Change in Device Propellant to Drive Adoption
3.7 Needle-Free Delivery Technology: Market Trends, 2016-2026
3.8 Needle-Free Delivery Technology: Drivers and Restraints, 2016-2026
4. Leading North American Needle-Free Injection Device Manufacturers, 2016
4.1 Antares Pharma
4.1.1 Antares Pharma: Financial Overview
4.1.2 Needle-Free Products
4.1.2.1 ZOMAJET™: Delivering Liquid Insulin or Human Growth Hormone
4.1.2.2 Vibex™: Hidden Needle to Alleviate Patient Fear
4.1.2.3 OTREXUP™: Combining Vibex MTX and Methotrexate
4.1.2.4 Vibex™ MTX: Targeting Growing Population of RA Sufferers
4.1.2.5 T-JET™
4.1.3 Needle-Free Injection Device Pipeline
4.1.3.1 Vibex™ QS (QuickShot): Modified Vibex to Offer Improved Function
4.1.3.2 Pen Injector: Devices Being Used Clinical Testing
4.1.3.3 VIBEX® QS T
4.1.3.4 VIBEX® QS M
4.2 Mylan Inc.
4.2.1 Mylan: Financial Overview
4.2.2 Needle-Free Products
4.2.2.1 EpiPen® Auto-Injector
4.2.2.2 EpiPen Jr® Auto-Injector
4.3 Bioject Medical Technologies
4.3.1 Bioject Medical Technologies: Financial Overview
4.3.2 Needle-Free Products
4.3.2.1 Biojector® 2000: Adaptable Power Source Allows Use in Home and Mass Vaccination Setting
4.3.2.2 Vitajet™: Low-Cost Insulin Delivery System
4.3.2.3 Bioject® ZetaJet™: Auto-Disable Feature Improves User Safety
4.3.2.4 Bioject® Drug Reconstitution System
4.3.2.5 Bioject® Needle-Free Vial Adapter
4.3.3 Needle-Free Injection Device Pipeline
4.3.3.1 Intradermal Pen Injector: Targeted Drug Delivery
4.3.3.2 Iject®: Providing Tailored Depth of Penetration
4.3.3.3 Iject® R: The Reusable Version
4.3.3.4 Jupiter Jet: Multi Dosing With Single Loaded Syringe
4.3.3.5 Mega Jet: The New Design
4.3.4 Collaborations
4.3.4.1 MPI Research: Seeking Drug/Device Combinations
4.3.4.2 World Health Organisation (WHO): The Push to Eradicate Infectious Disease in Developing Countries
4.4 Activa Brand Products, Inc.
4.4.1 Technology: The Activa Family for Diabetics
4.4.2 Needle-Free Products
4.4.2.1 Product Advantages
4.5 D’Antonio Consultants International Inc. (DCI)
4.5.1 Needle-Free Products
4.5.1.1 LectraJet®: Lightweight Device Reduces User Fatigue
4.5.2 Needle-Free Injection Device Pipeline
4.5.2.1 Low Workload Jet Injector: Single-Shot Manuel System
4.5.2.2 Multi-Channel Jet Injector: For Simultaneous Vaccine Delivery
4.6 National Medical Products, Inc.
4.6.1 Needle-Free Products
4.6.1.1 J-Tip®: Offering Needle-Free Administration of Anaesthesia
4.7 Medical International Technologies
4.7.1 Needle-Free Products
4.7.1.1 MED-JET®: Extremely Thin Orifice Offers Improved Drug Absorption
4.7.2 Increased Awareness Through Globalisation
4.8 Penjet Corporation
4.8.1 Needle-Free Products
4.8.1.1 Penjet®: Nitrogen-Powered Device Allows Efficient Storage
4.8.2 Applications
4.8.2.1 Multi-Component Drugs
4.8.2.2 Lyophilised Drug Delivery
4.8.2.3 Small Pox Vaccination
4.9 PharmaJet
4.9.1 Needle-Free Products
4.9.1.1 STRATIS®: Drug Delivery in Less Than a Second
4.9.2 Applications
4.9.3 Collaborations: Pursuing a Drug/Device Combination for Vaccine Administration
4.10 Valeritas
4.10.1 Needle-Free Products
4.10.1.1 Mini-Ject™: Potential Delivery of Lyophilised Drugs May Open Huge Opportunities for Valeritas
4.10.1.2 V-Go®: Click and Go Technology to Simplify Insulin Drug Delivery
4.10.1.3 Micro-Trans™:
4.10.1.4 h-Patch™: Controlled Delivery Patch
4.11 3M (MMM)
4.11.1 Needle-Free Products
4.11.1.1 3M: Metered Dose Inhaler
4.11.1.2 3M: Transdermal Patch
4.11.1.3 3M: Microneedle
4.12 Zogenix
4.12.1 Needle-Free Products
4.12.2 Needle-Free Injection Pipeline
4.13 BD – Becton, Dickinson and Company
4.13.1 Needle-Free Products
4.13.1.1 BD SmartSite
4.13.1.2 Soluvia
4.13.1.3 BD Ultra-Fine Nano Pen Needle
4.13.1.4 AutoShield Duo Pen Needle (BD)
4.13.1.5 BD Accuspray SCF Nasal Spray System
4.14 Portal Instruments
4.14.1 Needle-Free Products
4.14.1.1 Portal’s Needle-Free Jet Injector
4.14.1.2 Partnering
5. Leading European Needle-Free Injection Device Manufacturers, 2016
5.1 Akra Dermojet
5.1.1 Needle-Free Products
5.1.1.1 Dermojet® “HR”: User-Friendly Design Allows Use in High Intensive Applications
5.1.1.2 DERMOJET Polymedical®: Interchangeable Injection Tips Reduces Risk of Contamination
5.1.1.3 Automatic DERMOJET®
5.2 Crossject Medical Technology
5.2.1 Technology: Highly Customisable Device Allows Tailoring to Specific Drugs
5.2.2 Needle-Free Products
5.2.2.1 Zeneo®: Gas Propellant Generated Upon Injection
5.3 Glide Pharma
5.3.1 Needle-Free Products
5.3.1.1 Glide SDI®
5.3.1.2 Applications
5.3.2 Advantages
5.3.2.1 Injecting Solid Formulations
5.3.2.2 Pharmaceutical Companies
5.3.3 Collaboration With Pfenex Inc. to Aid Delivery of Solid Dose Vaccine
5.4 Merck KGaA
5.4.1 Needle-Free Products
5.4.1.1 Cool.click® and Cool.click2®
5.4.1.2 Click.easy®
5.4.1.3 SeroJet™
5.5 Spirit Healthcare
5.5.1 Spirit Healthcare Needle-Free Products
5.5.1.1 InsuJet™
5.6 AstraZeneca
5.6.1 AstraZeneca’s Needle-Free Product
6. Leading Emerging-Market Needle-Free Device Manufacturers, 2016
6.1 Injex Pharma AG
6.1.1 Needle-Free Products
6.1.1.1 INJEX30®: First Multiple Application Needle-Free Device?
6.2 Romsons Scientific & Surgical Pvt. Ltd.
6.2.1 Needle-Free Products
6.2.1.1 Safesite™
6.2.1.2 Exteena™ Uno
6.2.1.3 Exteena™ Duo
6.2.1.4 Exteena™ Trio
6.3 Binny’s Health Care Ltd
6.3.1 Needle-Free Products
6.3.1.1 Binny’s Needle-Free IV Injection
7. Leading Needle-Free Injection Companies in the Rest of the World, 2016
7.1 Mika Medical Co.
7.1.1 Needle-Free Products
7.1.1.1 Comfort-in™
7.2 JMS Singapore Pte Ltd
7.2.1 Needle-Free Products
7.2.1.1 Planecta™
7.3 B. Braun Singapore Pte Ltd.
7.3.1 Needle-Free Products
7.3.1.1 CARESITE® Luer Access Device (LAD)
7.3.1.2 SAFELINE® Split Septum Needleless Connector
7.3.1.3 ULTRASITE® Luer Access Device
7.4 NanoPass Technologies
7.4.1 Nanopass Drug Delivery Products
7.4.1.1 Micronjet Needle
7.4.1.2 Anti-Aging Microdermabrasion
7.5 Vaxxas
7.5.1 Needle-Free Products
7.5.1.1 The Nanopatch™
8. Qualitative Analysis of the Global Needle-Free Injection Device Market, 2016-2026
8.1 SWOT Analysis of the Global Needle-Free Injection Device Market, 2016-2026
8.1.1 Strengths
8.1.1.1 A Less Painful Alternative to Needle-Based Injections
8.1.1.2 No Specialist Training Required for Delivery
8.1.1.3 Strong Growth in the Biologic Drug Market
8.1.1.4 Increasing Development in Transdermal Delivery
8.1.1.5 Reduced Transport Costs and Eliminating the Cold Chain Problem
8.1.2 Weaknesses
8.1.2.1 Expensive Technology
8.1.3 Healthcare Practitioners Are Not Familiar with Novel Delivery Systems
8.1.3.1 Inefficient Manufacturing Process
8.1.4 Greater Regulatory Scrutiny
8.1.4.1 Off Patent/Generics Require Reformulating Prior to Use in Needle-Free Delivery Systems
8.1.5 Opportunities
8.1.5.1 Emerging Economies
8.1.5.2 Mass Immunisation Programmes
8.1.5.3 Shift Towards Home Administration Setting
8.1.5.4 Potential Delivery of Vaccines
8.1.5.5 Increasing Global Diabetes Population
8.1.5.6 Extending Life Cycle of Drugs
8.1.6 Threats
8.1.6.1 Traditional Needles and Syringes are Cheap to Mass Produce
8.1.6.2 Limited Clinical Data
8.1.6.3 Increased Scrutiny from Regulatory Bodies
8.1.6.4 Needle and Syringes with Anti Needlestick Injury Technology
8.2 STEP Analysis of the Global Needle-Free Injection Device Market, 2016-2026
8.2.1 Social Factors
8.2.2 Technological Developments
8.2.3 Economic Pressures
8.2.4 Political Issues
9. Research Interview
9.1 Mr David Hoey, CEO, Vaxxas
9.1.1 Vaxxas Overview
9.1.2 Introducing the Nanopatch™
9.1.3 Vaxxas’ Leading Strategy: Competition & Collaboration
9.1.4 Future Directions for Vaxxas and the Industry
10. Conclusions
10.1 The Global Needle-Free Injection Device Market, 2015-2026
10.2 Antares Pharma Dominates the Global Needle-Free Injection Device Market in 2016
10.3 Strong Pipeline Will Drive the Competing Needle-Free Injection Technology Market
10.4 The Future of the Needle-Free Technology Market?
10.5 Biosimilars are a Major Driver of the Needle Free Drug Delivery Market
10.6 Concluding Remarks
【レポート販売概要】
■ タイトル：医療機器リーダーシリーズ：世界の無針注射器開発、製造および販売におけるトップ企業2016■ 英文：Medical Device Leader Series: Top Needle-Free Injection Device Developers, Manufacturers and Marketers in 2016
■ 発行日：2016年6月
■ 調査会社：visiongain
■ 商品コード：VGAIN60711
■ 調査対象地域：グローバル
- アルファ1-アンチトリプシン薬の世界市場2016-2020About Alpha-1 antitrypsin Drugs Alpha-1 antitrypsin, also known as an alpha-1 protease inhibitor (A1PI), is a glycoprotein produced in the liver that helps in the inactivation of enzymes such as elastase, which break down proteins during inflammation induced by some injury. The decline in alpha-1 antitrypsin levels in the blood results in a rare genetic condition known as alpha-1 antitrypsin defic …
- 食品・サラダドレッシングの世界市場2016-2020About Food and Salad Dressings Food and salad dressings are used for garnishing and enhancing the taste of food products, especially salads, burgers, sandwiches, and other snack items. Some of the widely used dressings are mayonnaise, red wine oil, and vinegar and Caesar, Italian, and Russian dressings. Increased consumption of salads, as part of the move toward healthy eating, has created indirec …
- 胸部カテーテルの世界市場2019-2023About this market The rising patient preference toward minimally invasive surgeries will drive the thoracic catheters market growth globally. Minimally invasive surgeries including the laparoscopic surgery and robotic surgery will offer reduced healthcare costs, shorter hospital stays, and reduced postoperative complications. In addition, the growing trend toward robotic surgery is gaining momentu …
- クラウド式ITセキュリティサービスの世界市場2016-2020About the IT security as a service market The global IT security as a service market is growing steadily as cloud services remain the most promising market over the decade. Organizations can reduce risks by virtualizing applications and users, and integrating data leak protection functions into a secure cloud-hosted environment. This enables users to experience an improved traditional environment, …
- ウィルソン病治療薬の世界市場2019-2023129 pages, October 2018 About this market The increase in strategic alliances to help market grow. Pharmaceutical companies are engaging in strategic alliances for the development of medications for the treatment of Wilson’s disease. These alliances enhance the R&D activities for new drugs for the treatment of Wilson’s disease. Technavio’s analysts have predicted that the Wilson’s disease drugs ma …
- 弾薬の世界市場予測（～2021年）“Growing geopolitical tensions across the globe are expected to fuel the growth of the global ammunition market during the forecast period, 2016 to 2021.” The global ammunition market is projected to grow from USD 18.08 billion in 2016 to USD 21.98 billion by 2021, at a CAGR of 3.98% from 2016 to 2021. This growth can be attributed mainly to factors, such as territorial conflicts, military moderni …
- 世界の医療産業におけるMEMS技術動向（2012-2016）TechNavio's analysts forecast the Global MEM Technology market in the Healthcare industry to grow at a CAGR of 34.8 percent over the period 2012-2016. One of the key factors contributing to this market growth is the growing need for high operating speed medical devices. The Global MEM Technology market in the Healthcare industry has also been witnessing the miniaturization of medical electronic de …
- 組み込みプロセッサのグローバル市場（2014-2018）About Embedded Processor An embedded processor is a single chip that encompasses the functions of several discrete chips. Embedded processors are integrated in the embedded systems which are used to carry out complex operations. Embedded processors are different from other processors because of their architecture which entails dedicated computing cores (a processor), memory, and programmable input …
- 太陽光発電インバーター用バッテリーの世界市場Market outlook of the global battery market for solar PV inverters Technavio’s market research analyst has estimated factors like the rising market competition and growing supply chain efficiency to bolster market growth during the forecast period. These factors help the global battery market for solar PV inverters to grow at a rapid rate during the forecast period and results in its impressive CA …
- 世界のBaaS(Backend as a Service)市場動向（2012-2016）TechNavio's analysts forecast the Global Backend-as-a-Service (BaaS) market to grow at a CAGR of 100.9 percent over the period 2012-2016. One of the key factors contributing to this market growth is the need to reduce complexity of application development. The Global BaaS market has also been witnessing the increasing penetration of smartphones and tablets. However, the lack of end-user control co …
- 家畜用グローライトの世界市場予測（～2023年）“Increase in the demand and consumption of animal-based products such as dairy and dairy-based products, meat, and eggs are projected to drive the overall growth of the livestock grow lights market.” The global livestock grow lights market size is projected to grow from USD 6.3 billion in 2018 to USD 8.6 billion by 2023, at a CAGR of 6.4% during the forecast period. The livestock grow lights marke …
- 植物生育箱（グロースチャンバー）の世界市場2018-2022About Plant Growth Chamber Plant growth chambers are a special type of environmental test chambers that are designed to perform plant growth experiments inside the laboratory to maximize plant growth. They facilitate the control of temperature, light, and humidity, to create a favorable environment in the chambers required for research and testing of a seed or plant. Technavio’s analysts forecast …
- 治療薬物モニタリングの世界市場2015During the next decade, the TDM market will undergo significant transformation. These changes will be caused by convergence of new and more stringent regulations; advances in diagnostic technologies, system engineering, automation, and IT; and intensifying competition. Some segments will start resembling commodity markets, where product positioning and cost per test are more critical than underlyi …
- 金属酸化物ナノ粒子の世界市場2017-2021ABSTRACTAbout Metal Oxide Nanoparticles Nanoparticles of metal oxides with a particle size of 1-100 nm are called metal oxide nanoparticles. They are available in various shapes such as spherical, octagonal, diamond, and thin sheets. Since the advent of nanotechnology, metal oxide nanomaterials have been at the center of research. Although these nanomaterials are widely used in the commercial and …
- 産業用ワイヤレスオートメーションの世界市場2019-2023About this market Wireless technologies have evolved over the years to simplify business operations across the end-user industries. Advances in wireless solutions have empowered end-users to deploy M2M services for managing several facets of business. The major factor driving the M2M communications is the pervasive accessibility of low cost, ubiquitous connectivity. M2M, in general, is a next-gene …
